Eva Rodríguez-Suárez - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Mass Spectrometry Reviews|August 1, 2012

The application of quantification techniques in proteomics for biomedical researchEva Rodríguez-Suárez, Anthony D Whetton

Biochimica Et Biophysica Acta|July 9, 2013

Urine as a source for clinical proteome analysis: from discovery to clinical applicationEva Rodríguez-Suárez, Justyna Siwy, Petra Zürbig, et al.

Proteomics|February 9, 2010

Virtual expert mass spectrometrist: iTRAQ tool for database-dependent search, quantitation and result storageEva Rodríguez-Suárez, Ewa Gubb, Itziar Frades Alzueta, et al.

Proteomics|June 15, 2007

Computational approach for identification and characterization of GPI-anchored peptides in proteomics experimentsMiren J Omaetxebarria, Felix Elortza, Eva Rodríguez-Suárez, et al.

Proteomics|August 14, 2010

Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approachesChia Fang Lee, Stephen Griffiths, Eva Rodríguez-Suárez, et al.

Proteomics. Clinical Applications|December 8, 2010

Non-alcoholic fatty liver disease proteomicsEva Rodríguez-Suárez, Antonio M Duce, Juan Caballería, et al.

Journal of Proteomics|April 22, 2014

Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityEva Rodríguez-Suárez, Esperanza Gonzalez, Chris Hughes, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With PolyangiitisParameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.

ERJ Open Research|March 11, 2026

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitisManali Mukherjee, Nadia Suray Tan, Chynna Huang, et al.

Annals of the Rheumatic Diseases|August 8, 2025

Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitisPeter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Mass Spectrometry Reviews|August 1, 2012

The application of quantification techniques in proteomics for biomedical researchEva Rodríguez-Suárez, Anthony D Whetton

Biochimica Et Biophysica Acta|July 9, 2013

Urine as a source for clinical proteome analysis: from discovery to clinical applicationEva Rodríguez-Suárez, Justyna Siwy, Petra Zürbig, et al.

Proteomics|February 9, 2010

Virtual expert mass spectrometrist: iTRAQ tool for database-dependent search, quantitation and result storageEva Rodríguez-Suárez, Ewa Gubb, Itziar Frades Alzueta, et al.

Proteomics|June 15, 2007

Computational approach for identification and characterization of GPI-anchored peptides in proteomics experimentsMiren J Omaetxebarria, Felix Elortza, Eva Rodríguez-Suárez, et al.

Proteomics|August 14, 2010

Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approachesChia Fang Lee, Stephen Griffiths, Eva Rodríguez-Suárez, et al.

Proteomics. Clinical Applications|December 8, 2010

Non-alcoholic fatty liver disease proteomicsEva Rodríguez-Suárez, Antonio M Duce, Juan Caballería, et al.

Journal of Proteomics|April 22, 2014

Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityEva Rodríguez-Suárez, Esperanza Gonzalez, Chris Hughes, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With PolyangiitisParameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.

ERJ Open Research|March 11, 2026

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitisManali Mukherjee, Nadia Suray Tan, Chynna Huang, et al.

Annals of the Rheumatic Diseases|August 8, 2025

Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitisPeter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.

Pageof 1